|
Volumn 1 Suppl 1, Issue , 2000, Pages
|
Epirubicin in breast cancer: present and future.
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC ANTIBIOTIC;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
EPIRUBICIN;
ADJUVANT CHEMOTHERAPY;
BIOSYNTHESIS;
BREAST TUMOR;
DOSE RESPONSE;
FEMALE;
HUMAN;
METASTASIS;
PATHOLOGY;
REVIEW;
ANTIBIOTICS, ANTINEOPLASTIC;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
DOSE-RESPONSE RELATIONSHIP, DRUG;
EPIRUBICIN;
FEMALE;
HUMANS;
NEOPLASM METASTASIS;
RECEPTOR, ERBB-2;
MLCS;
MLOWN;
|
EID: 21544458650
PISSN: 15268209
EISSN: None
Source Type: Journal
DOI: 10.3816/cbc.2000.s.012 Document Type: Review |
Times cited : (9)
|
References (34)
|